Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

4 Stocks To Watch: ACET, CENT, JBLU, NHTC

Published 10/13/2015, 12:49 AM
Updated 07/09/2023, 06:31 AM

It was a really interesting day on Wall Street on Monday, a little choppy, a little sloppy, and a little worrisome. When markets go up and technicals are not cooperating, it is not good. Negative divergences or lack of cooperation are the first things that show a market is getting long in the tooth, tired, or ready to rollover. Be careful the next day or two especially. There are still some stocks that are acting strong. Lets take a look at some of them.

Aceto Corp. (O:ACET), which we’ve mentioned a couple times, particularly on the breakaway gap, the run-up, it formed a wedge, and on Monday, it broke out of the wedge, up 1.58 to 29.61, or 5.6%, on 272,100. The volume wasn't huge. It’s not a heavily traded stock. It does have 3.2 days to cover. The breakout could get a retest up near the 31.90 area, maybe even 32.00 short-term.

Central Garden & Pet Company (O:CENT) has really been strong the last couple of months, and on Monday, it was up 96 cents to 17.27, or 5.9%, on 242,600 shares traded. It has gone from 8 1/2 to 17 1/2. Doubling, yet the longer-term chart shows a major breakout at the 2006 high up around 18.50-.60. That could be the target short-term, and then it could take it further.

JetBlue Airways Corporation (O:JBLU) is one of several airlines that did great on Monday, up 76 cents to 26.86, or 2.9%, on 6.1 million shares. It broke out of a consolidation pattern, and may very well be on its way to 30-31.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Natural Health Trends Corp. (O:NHTC) has been going very strong since late August. On Monday, it was up 4.31 to 35.64, or 12%, on 470,000 shares traded. It’s going to come up against the double-top that comes in around 44 3/4. I love the declining topsline break, and the pullback to test the 50. From that level it has gone to 28 1/4, and then to 401/2 in just a week and a half. That’s the near-term target, but ultimately, this stock could get up into the high 50’s.

Other stocks on the long side include Aquinox Pharmaceuticals Inc. (O:AQXP), Anavex Life Sciences Corp. (OTC:AVXLD), Can-Fite BioPharma Ltd. (N:CANF), Eros International (N:EROS), Entravision Communications Corporation (N:EVC), SkyWest Inc. (O:SKYW), Juno Therapeutics Inc. (O:JUNO), NovoCure Limited (O:NVCR), and Pure Storage, Inc. (PSTG).

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.